NO20074355L - Oral osmotisk doseringsform som har en hoy fluksmembran - Google Patents

Oral osmotisk doseringsform som har en hoy fluksmembran

Info

Publication number
NO20074355L
NO20074355L NO20074355A NO20074355A NO20074355L NO 20074355 L NO20074355 L NO 20074355L NO 20074355 A NO20074355 A NO 20074355A NO 20074355 A NO20074355 A NO 20074355A NO 20074355 L NO20074355 L NO 20074355L
Authority
NO
Norway
Prior art keywords
dosage form
osmotic dosage
oral osmotic
weight percent
high flux
Prior art date
Application number
NO20074355A
Other languages
English (en)
Inventor
David E Edgren
Robert Skluzacek
Gurdish K Bhatti
Shu Li
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20074355L publication Critical patent/NO20074355L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det beskrives en oral, osmotisk doseringsform og metoder der en semipermeabel membran i den orale, osmotiske doseringsform inkluderer fra rundt 23 vektprosent til rundt 50 vektprosent av en fluksforsterker og fra rundt 0,01 vektprosent til rundt 5 vektprosent antioksidant, beregnet på den totale tørrvekt av den semipermeable membranen. Slike preparater gir høyfluksmembraner med forbedret mekanisk og transportstabilitet under lagring.
NO20074355A 2005-01-27 2007-08-27 Oral osmotisk doseringsform som har en hoy fluksmembran NO20074355L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64786405P 2005-01-27 2005-01-27
PCT/US2006/003273 WO2006081569A2 (en) 2005-01-27 2006-01-27 Oral osmotic dosage form having a high flux membrane

Publications (1)

Publication Number Publication Date
NO20074355L true NO20074355L (no) 2007-10-18

Family

ID=36639035

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074355A NO20074355L (no) 2005-01-27 2007-08-27 Oral osmotisk doseringsform som har en hoy fluksmembran

Country Status (10)

Country Link
US (1) US20060165798A1 (no)
EP (1) EP1858492B1 (no)
JP (1) JP2008528629A (no)
AT (1) ATE413864T1 (no)
CA (1) CA2596029A1 (no)
DE (1) DE602006003639D1 (no)
HK (1) HK1111090A1 (no)
NO (1) NO20074355L (no)
WO (1) WO2006081569A2 (no)
ZA (1) ZA200707187B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2745612A1 (en) * 2008-12-04 2010-06-10 The University Of Akron Polymer composition and dialysis membrane formed from the polymer composition
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
EP2558088A4 (en) 2010-04-14 2014-01-15 Univ Akron POLYMER COMPOSITION COMPRISING A PHYTOCHIMIC AGENT AND DIALYSIS MEMBRANE FORMED FROM THE POLYMER COMPOSITION
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形
CN104225608B (zh) * 2013-06-20 2017-07-28 中国科学院上海药物研究所 源自胖大海的天然膨胀性基质在渗透泵制剂中的用途
JP7064285B2 (ja) * 2013-12-06 2022-05-10 デュレクト コーポレーション 抗酸化剤を含む組成物、流体分注器、及びそれらに関わる方法
US10172842B2 (en) * 2015-09-11 2019-01-08 PharmaDax Inc. Sustained release oral dosage form containing dalfampridine

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2707154A (en) * 1952-06-09 1955-04-26 Monsanto Chemicals Antioxidants and compositions containing same
US3173876A (en) * 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
NL271831A (no) * 1960-11-29
US3276586A (en) * 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
US3546142A (en) * 1967-01-19 1970-12-08 Amicon Corp Polyelectrolyte structures
CH508415A (de) * 1967-10-27 1971-06-15 Hoffmann La Roche Antioxydative Mischung und deren Verwendung
US3573936A (en) * 1967-12-15 1971-04-06 Rayonier Inc Plicatic acid and thiodipropionic acid as antioxidants for use in animal fats and vegetable oils
US3541006A (en) * 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) * 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US3995631A (en) * 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US3723147A (en) * 1971-11-03 1973-03-27 Eastman Kodak Co Stabilizer system for cellulose ester plastics
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4038434A (en) * 1976-03-12 1977-07-26 Howard Hall & Company Antioxidant stabilized edible compositions
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4111201A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4137201A (en) * 1977-09-02 1979-01-30 Eastman Kodak Company Cyclic phosphonite stabilized cellulose ester compositions
US4186465A (en) * 1978-03-28 1980-02-05 Manning Jim L Safety lock
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
IN159370B (no) * 1982-01-15 1987-05-09 Ciba Geigy Ag
US4519801A (en) * 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US5082668A (en) * 1983-05-11 1992-01-21 Alza Corporation Controlled-release system with constant pushing source
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4839405A (en) * 1986-07-08 1989-06-13 Plasticolors, Inc. Ultraviolet stabilizer compositions, stabilized organic materials, and methods
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
WO1990008536A1 (en) * 1989-01-30 1990-08-09 Alza Corporation Dosage form for administering calcium antagonist
US5091190A (en) * 1989-09-05 1992-02-25 Alza Corporation Delivery system for administration blood-glucose lowering drug
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
US6551613B1 (en) * 1998-09-08 2003-04-22 Alza Corporation Dosage form comprising therapeutic formulation
US6174547B1 (en) * 1999-07-14 2001-01-16 Alza Corporation Dosage form comprising liquid formulation
WO2000025753A2 (en) * 1998-11-02 2000-05-11 Alza Corporation Controlled delivery of active agents
DK1140012T3 (da) * 1998-12-17 2004-07-12 Alza Corp Omdannelse af væskefyldte gelatinekapsler til systemer til kontrolleret frigivelsessystemer ved flere coatinger
US6342249B1 (en) * 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US6767937B2 (en) * 2001-10-03 2004-07-27 Eastman Kodak Company Stabilizer system for polymer components of displays
KR20050034645A (ko) * 2002-05-31 2005-04-14 알자 코포레이션 다양한 용량의 옥시코돈을 삼투 전달하기 위한 제형 및조성물
WO2004010970A1 (en) * 2002-07-29 2004-02-05 Alza Corporation Formulations and dosage forms for controlled delivery of topiramate

Also Published As

Publication number Publication date
ATE413864T1 (de) 2008-11-15
CA2596029A1 (en) 2006-08-03
JP2008528629A (ja) 2008-07-31
ZA200707187B (en) 2008-12-31
DE602006003639D1 (de) 2008-12-24
WO2006081569A2 (en) 2006-08-03
HK1111090A1 (en) 2008-08-01
US20060165798A1 (en) 2006-07-27
WO2006081569A3 (en) 2006-09-21
EP1858492A2 (en) 2007-11-28
EP1858492B1 (en) 2008-11-12

Similar Documents

Publication Publication Date Title
NO20074355L (no) Oral osmotisk doseringsform som har en hoy fluksmembran
EA201100153A1 (ru) Никотинсодержащие мягкие желатиновые пастилки
EA200971018A1 (ru) Новая фармацевтическая композиция
EA200701660A1 (ru) Композиции и способы, предназначенные для хранения эритроцитов
NO20071095L (no) Hittil ukjente tiofenderivater
EA200601303A1 (ru) Система ретрансляторов сигнала
CY1113069T1 (el) Μεθοδοι παρασκευης συνθεσεων ξηρης σκονης του γλυκοπυρρολικου
NO20065701L (no) Orodispersibel farmasoytisk sammensetning for oromukosal eller sublingval administrasjon av agomelatin
NO20070373L (no) Aerosol suspensjonsformulering inneholdende TG 227 EA eller TG 134 A som et drivmiddel
BRPI0513332A (pt) formulação de interferon peguilado estável
NO20050801L (no) Prodrug av protonpumpe inhibitorer
NO20072714L (no) Forbedret baereformulering
AR048534A1 (es) Formulaciones de acetato de bazedoxifeno
BR112014010814A2 (pt) composições de herbicida/fitoprotetor contendo amidas do ácido n-(tetrazol-5-il) aril carboxílico e amidas do ácido n-(triazol-5-il) aril carboxílico
NO20080991L (no) Bazedoksifen acetat formuleringer
AR107927A1 (es) Compuestos de pirrolidina, sal farmacéuticamente aceptable del mismo, composición farmacéutica que lo comprende y su uso para la fabricación de un medicamento
ATE427039T1 (de) Tee-aromatisierung
ECSP088270A (es) Derivados de (indol-3-il)-heterociclo como agonistas del receptor cannabinoide cb1
DK1196196T3 (da) Konjugat til formidling af en celle-, compartment- eller membranspecifik transport af aktivstoffer
EA201071098A1 (ru) Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
JP2004534810A5 (no)
TR201009394A2 (tr) Geliştirilmiş montelukast formülasyonları.
MX2022007988A (es) Formas cristalinas de (s)-1-(1-acriloilpirrolidin-3-il)-3-((3,5-di metoxifenil)etinil)-5-(metilamino)-1h-pirazol-4-carboxamida.
NO20055311L (no) Farmasoytisk aktive ornitinderivater, ammoniumsalter derav og fremgangsmater for fremstilling av det samme
NO20073046L (no) Utvalgte benzofuranderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application